These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25648080)

  • 21. Renoprotective antioxidant effect of alagebrium in experimental diabetes.
    Park J; Kwon MK; Huh JY; Choi WJ; Jeong LS; Nagai R; Kim WY; Kim J; Lee GT; Lee HB; Ha H
    Nephrol Dial Transplant; 2011 Nov; 26(11):3474-84. PubMed ID: 21478303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary NGAL and RBP Are Biomarkers of Normoalbuminuric Renal Insufficiency in Type 2 Diabetes Mellitus.
    Li A; Yi B; Liu Y; Wang J; Dai Q; Huang Y; Li YC; Zhang H
    J Immunol Res; 2019; 2019():5063089. PubMed ID: 31637265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
    Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
    Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.
    Satirapoj B; Pooluea P; Nata N; Supasyndh O
    J Diabetes Complications; 2019 Sep; 33(9):675-681. PubMed ID: 31227289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium Bicarbonate Supplementation and Urinary TGF-
    Raphael KL; Greene T; Wei G; Bullshoe T; Tuttle K; Cheung AK; Beddhu S
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):200-208. PubMed ID: 31974286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
    Gallo LA; Ward MS; Fotheringham AK; Zhuang A; Borg DJ; Flemming NB; Harvie BM; Kinneally TL; Yeh SM; McCarthy DA; Koepsell H; Vallon V; Pollock C; Panchapakesan U; Forbes JM
    Sci Rep; 2016 May; 6():26428. PubMed ID: 27226136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NF-κB Inhibitor Parthenolide Promotes Renal Tubules Albumin Uptake in Type 2 Diabetic Nephropathy.
    Hao QF; Wang BB; Zhang W; Qiu W; Liu QL; Li XM
    Chin Med Sci J; 2020 Mar; 35(1):31-42. PubMed ID: 32299536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
    Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
    J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ferroptosis Enhanced Diabetic Renal Tubular Injury
    Feng X; Wang S; Sun Z; Dong H; Yu H; Huang M; Gao X
    Front Endocrinol (Lausanne); 2021; 12():626390. PubMed ID: 33679620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice.
    Cohen MP; Hud E; Shea E; Shearman CW
    Metabolism; 2002 Jul; 51(7):901-5. PubMed ID: 12077739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes.
    Żyłka A; Gala-Błądzińska A; Dumnicka P; Ceranowicz P; Kuźniewski M; Gil K; Olszanecki R; Kuśnierz-Cabala B
    Dis Markers; 2016; 2016():8489543. PubMed ID: 28050059
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of early biomarkers of renal dysfunction in diabetic patients.
    Al-Hazmi SF; Gad HGM; Alamoudi AA; Eldakhakhny BM; Binmahfooz SK; Alhozali AM
    Saudi Med J; 2020 Jul; 41(7):690-697. PubMed ID: 32601635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative diagnostic utility of different urinary biomarkers during pre-albuminuric stages of non-hypertensive type 2 diabetic nephropathy.
    Mahapatra HS; Kulshreshtha B; Goyal P; Chitkara A; Kumari A; Arora A; Sekhar V; Gupta YP
    Indian J Med Res; 2022 Jul; 156(1):46-55. PubMed ID: 36510897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model.
    Boonloh K; Lee ES; Kim HM; Kwon MH; Kim YM; Pannangpetch P; Kongyingyoes B; Kukongviriyapan U; Thawornchinsombut S; Lee EY; Kukongviriyapan V; Chung CH
    Eur J Nutr; 2018 Mar; 57(2):761-772. PubMed ID: 28004272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
    Nielsen SE; Schjoedt KJ; Astrup AS; Tarnow L; Lajer M; Hansen PR; Parving HH; Rossing P
    Diabet Med; 2010 Oct; 27(10):1144-50. PubMed ID: 20854382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Hyperbaric Oxygen Therapy on Inflammation, Oxidative/Antioxidant Balance, and Muscle Damage after Acute Exercise in Normobaric, Normoxic and Hypobaric, Hypoxic Environments: A Pilot Study.
    Woo J; Min JH; Lee YH; Roh HT
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33050362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum and urinary SOD3 in patients with type 2 diabetes: comparison with early chronic kidney disease patients and association with development of diabetic nephropathy.
    Kuo CW; Chen HL; Tu MY; Chen CM
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F32-F41. PubMed ID: 30303710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy.
    Kim SY; Jeong TD; Lee W; Chun S; Sunwoo S; Kim SB; Min WK
    Ann Lab Med; 2018 Nov; 38(6):524-529. PubMed ID: 30027695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.